![Imcyse to present positive results in EAE model of multiple sclerosis at ECTRIMS 2019](https://ala.associates/wp-content/uploads/2022/04/12-seot.jpg)
![Imcyse to present positive results in EAE model of multiple sclerosis at ECTRIMS 2019](https://ala.associates/wp-content/uploads/2022/04/12-seot.jpg)
![Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098](https://ala.associates/wp-content/uploads/2022/04/IMCYSE_Pierre_Vandepapeliere-1-300x250-1.jpg)
Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098
![GamaMabs Pharma announces presentation of murlentamab phase 2 study results in colorectal cancer at ESMO World Congress on Gastrointestinal Cancer](https://ala.associates/wp-content/uploads/2022/04/Stephane-Degove-GamaMabs-Pharma-500x250-1.jpg)
GamaMabs Pharma announces presentation of murlentamab phase 2 study results in colorectal cancer at ESMO World Congress on Gastrointestinal Cancer
![Minoryx Therapeutics announces first patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia](https://ala.associates/wp-content/uploads/2022/04/Minoryx-logo.png)
Minoryx Therapeutics announces first patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia
![GamaMabs Pharma announces presentation of murlentamab phase 2 study results in colorectal cancer at ESMO World Congress on Gastrointestinal Cancer](https://ala.associates/wp-content/uploads/2022/04/Stephane-Degove-GamaMabs-Pharma-500x250-1.jpg)
GamaMabs Pharma to present updated results at 2019 ASCO Annual Meeting from the First-In-Human clinical study of murlentamab in advanced gynecological cancers
![Neuroprotection Biotech Bionure Reports Successful Phase 1 Study for Lead Candidate BN201](https://ala.associates/wp-content/uploads/2022/04/Dr.-Pablo-Villoslada-500x250-1.jpg)
Neuroprotection Biotech Bionure Reports Successful Phase 1 Study for Lead Candidate BN201
![CarThera publishes complete results of Phase I/IIa clinical trial using its SonoCloud-1 ultrasound implant for treatment of glioblastoma](https://ala.associates/wp-content/uploads/2022/04/SonoCloud111-500x250-1.png)
CarThera publishes complete results of Phase I/IIa clinical trial using its SonoCloud-1 ultrasound implant for treatment of glioblastoma
![HypnoVR confirms validity of virtual reality hypnosis through three clinical studies](https://ala.associates/wp-content/uploads/2022/04/HYPNO-VR_WEB-Management-team-2-500x250-1.jpg)
HypnoVR confirms validity of virtual reality hypnosis through three clinical studies
Alizé Pharma 3 to present data from its AZP-3404 program at ENDO 2019
![Pherecydes Pharma reports successful patient treatment with bacteriophages](https://ala.associates/wp-content/uploads/2022/04/Jerome-Gabard-1-500x250-1.jpg)